| dc.creator |
Yavas, Cagdas |
|
| dc.creator |
Celik, Esin |
|
| dc.creator |
Elsurer, Cagdas |
|
| dc.creator |
Yavas, Guler |
|
| dc.creator |
Afsar, Rengin |
|
| dc.date |
2017-06-30T21:00:00Z |
|
| dc.date.accessioned |
2020-10-06T11:37:41Z |
|
| dc.date.available |
2020-10-06T11:37:41Z |
|
| dc.identifier |
e4820e58-1eab-4b94-a75e-b6395c24df1f |
|
| dc.identifier |
10.1016/j.rpor.2017.01.004 |
|
| dc.identifier |
https://avesis.sdu.edu.tr/publication/details/e4820e58-1eab-4b94-a75e-b6395c24df1f/oai |
|
| dc.identifier.uri |
http://acikerisim.sdu.edu.tr/xmlui/handle/123456789/74592 |
|
| dc.description |
Aim: We aimed to evaluate impact of spironolactone (S) on cardiovascular toxicity of concomitant use of radiotherapy (RT) and trastuzumab (T). |
|
| dc.language |
eng |
|
| dc.rights |
info:eu-repo/semantics/closedAccess |
|
| dc.title |
Spironolactone ameliorates the cardiovascular toxicity induced by concomitant trastuzumab and thoracic radiotherapy |
|
| dc.type |
info:eu-repo/semantics/article |
|